NorthWest Biotherapeutics Inc (NWBO)

[Pyrrhonian]

Rk, one clarification:

on pg 5 here: http://clincancerres.aacrjournals.org/content/17/16/5473.full.pdf

It shows rates by month (they were checked every 4 weeks in the study). It shows the sharpest drop over the first month, followed by more decline over the second month, followed by some retracing. Lymph and CD4 dropped equally bad to 50% of baseline after 4 weeks. I imagine most of this was within the 2-4 week window after SOC that patients who are tested for eligibility for the DCVax-L trial fall into.